Showing CypComp Card for CC00602: MK-0767 (CypReact Training Set)

Record Information
Version1.0
Creation Date2019-07-14 16:22:43 UTC
Last Updated2019-10-01 21:38:18 UTC
CypComp IDCC00602
Compound Information
NameMK-0767
Structure ImageRxrulmgjksldfm inizcteosa n
InChIKeyRXRULMGJKSLDFM-INIZCTEOSA-N
PubChem ID87173364
CypCompound Information
SetCypReact Training Set
Reactant Statuses
CYP1A2CYP2A6CYP2B6CYP2C8CYP2C9CYP2C19CYP2D6CYP2E1CYP3A4
Non-ReactantNon-ReactantNon-ReactantNon-ReactantNon-ReactantNon-ReactantNon-ReactantNon-ReactantReactant
References
  1. Liu DQ, Karanam BV, Doss GA, Sidler RR, Vincent SH, Hop CE: In vitro metabolism of MK-0767 [(+/-)-5-[(2,4-dioxothiazolidin-5-yl)methyl]-2-methoxy-N-[[(4-trifluoromethyl)-ph enyl] methyl]benzamide], a peroxisome proliferator-activated receptor alpha/gamma agonist. II. Identification of metabolites by liquid chromatography-tandem mass spectrometry. Drug Metab Dispos. 2004 Sep;32(9):1023-31. doi: 10.1124/dmd.104.000059. [PubMed:15319345 ]
Download FileCC00602.sdf